Stay updated on Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial

Sign up to get notified when there's something new on the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    No significant changes detected between the old and new page; only minor formatting or layout differences observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:52:47.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources; - Updated software version from v3.1.0 to v3.2.0; - Removed the old version reference.
    Difference
    5%
    Check dated 2025-10-06T04:25:49.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Expanded topic coverage to include Sudden Infant Death Syndrome and related terms, with a new revision v3.1.0; previous revision v3.0.2 removed.
    Difference
    1%
    Check dated 2025-09-29T00:58:27.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' link; overall, a minor update with no changes to pricing, stock, or dates.
    Difference
    0.3%
    Check dated 2025-09-14T18:44:27.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.3%
    Check dated 2025-09-07T13:05:02.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of specific medical conditions and a new facility name and location, while removing previous location details and certain medical terms.
    Difference
    7%
    Check dated 2025-08-31T03:57:48.000Z thumbnail image

Stay in the know with updates to Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page.